(MedPage Today) -- The combination of GLP-1 agonists and basal insulin beat other type 2 diabetes treatments at lowering HbA1c and improving glycemic control, researchers found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment